Related Experiment Video
Updated: May 4, 2026

12:23
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
14.2K
Comparing Lesion Volume Dynamics Between Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder During
Shaun G Hong1,2, Ki Hoon Kim2,3, You-Ri Kang2,4
1Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN, USA.
Journal of Clinical Neurology (Seoul, Korea)
|August 29, 2025
Summary
Subclinical brain lesions accumulate significantly in multiple sclerosis (MS) patients during remission, unlike in neuromyelitis optica spectrum disorder (NMOSD). This finding underscores the distinct disease mechanisms and need for tailored treatments for MS and AQP4+ NMOSD.
Area of Science:
- Neuroimmunology
- Neuroimaging
- Machine Learning in Medicine
Background:
- Multiple sclerosis (MS) and aquaporin-4-positive neuromyelitis optica spectrum disorder (AQP4+ NMOSD) are distinct inflammatory demyelinating diseases of the central nervous system.
- Subclinical lesion progression during remission is poorly understood in both MS and NMOSD.
- Machine learning (ML) offers advanced quantitative analysis of brain lesions on MRI.
Purpose of the Study:
- To compare subclinical lesion volume changes between MS and AQP4+ NMOSD patients during remission.
- To utilize ML-based lesion segmentation for precise volumetric assessment.
- To investigate differences in disease activity during inter-attack periods.
Main Methods:
- Retrospective analysis of 3D brain MRI scans from 31 MS and 30 AQP4+ NMOSD patients.
- Application of ML-based segmentation for lesion quantification.
- Statistical analysis of lesion volume changes during the remission period.
Main Results:
- MS patients showed a significant median lesion volume increase (3,493 mm³ to 4,430 mm³, p<0.001), indicating ongoing subclinical activity.
- NMOSD patients exhibited no significant change in median lesion volume (640 mm³ to 930 mm³, p=0.129), suggesting an attack-dependent course.
- Annual lesion volume increase was substantially higher in MS (193 mm³/year) compared to NMOSD (25 mm³/year, p=0.017).
Conclusions:
- MS and AQP4+ NMOSD demonstrate fundamentally different pathogenic processes.
- Distinct disease mechanisms necessitate specialized therapeutic and monitoring strategies for each condition.
- ML-based neuroimaging is crucial for understanding subclinical disease progression in demyelinating disorders.

